| Offering Information |
| Expected Date | WITHDRAWN |
| Proposed Exchange/Ticker |
Nasdaq: MSRX |
| Security Type |
Common Stock |
| Lead Underwriter |
Cowen |
| Days In Registration |
318 |
| Date Filed |
14-May-2007 |
| Form Filed | S-1 |
Fundamentals
(Year Ending December 2008) |
| Industry |
Manufacturing |
| Business Description |
MonoSol Rx offers Rapidly Dissolving Films for prescription and Over-The-Counter drugs using proprietary drug delivery technology; These films dissolve instantaneously when placed on the tongue and are also called ODFs or Orally Dissolving Films |
| Revenue |
- |
| Net Income |
- |
| Shares Outstanding (post-offering) |
15.03M |
| Contact |
- |
| Number of Employees |
- |
|
| Original Filing Information |
| US |
| Shares Filed |
4.0M |
| Secondary Shares Filed | - |
| · As a Percent |
- |
| Primary Shares Filed |
- |
| · As a Percent |
- |
| Overallotment Shares Filed |
600.0K |
| File Amount |
- |
| File Price Range |
$18.00 - $16.00 |
| File Mid Price |
$17.00 |
|
